Podchaser Logo
Home
Four-Factor PCC vs Andexanet Alfa for the Reversal of DOACs In Traumatic Brain Injuries

Four-Factor PCC vs Andexanet Alfa for the Reversal of DOACs In Traumatic Brain Injuries

Released Tuesday, 14th May 2024
Good episode? Give it some love!
Four-Factor PCC vs Andexanet Alfa for the Reversal of DOACs In Traumatic Brain Injuries

Four-Factor PCC vs Andexanet Alfa for the Reversal of DOACs In Traumatic Brain Injuries

Four-Factor PCC vs Andexanet Alfa for the Reversal of DOACs In Traumatic Brain Injuries

Four-Factor PCC vs Andexanet Alfa for the Reversal of DOACs In Traumatic Brain Injuries

Tuesday, 14th May 2024
Good episode? Give it some love!
Rate Episode

ACCP EM PRN Journal Club: March 2024


Presenter: Caitlin Lemmons, PharmD | PGY-1 Pharmacy Resident | @caitlinlemmons | Nebraska Medicine

Article presented: https://pubmed.ncbi.nlm.nih.gov/38267194/


Copyright Notice: By accessing this podcast, you understand and acknowledge that its contents and materials are the property of ACCP and the Emergency Medicine PRN. Further, the podcast, its contents and its materials are protected under United States and international copyright and trademark law. You understand that the podcast, its contents or materials are to be used only for personal or non-commercial purposes.


Limitation of Liability; ACCP AND THE EMERGENCY MEDICINE PRN DISCLAIM ANY AND ALL LIABILITY OR RESPONSIBILITY FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR ANY OTHER DAMAGES, INCLUDING WITHOUT LIMITATION, LOSS OF PROFITS, ARISING OUT OF ANY USE OF, REFERENCE TO, RELIANCE ON, OR INABILITY TO USE THE PODCAST, ITS CONTENTS AND MATERIAL

Produced by Christian Kroll, PharmD, BCPS

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features